Article
Detecting protein losing enteropathy by Tc-99m dextran scintigraphy: a novel experience.
Department of Pediatrics, MAMC and allied LN Hospital, New Delhi.
The Indian Journal of Pediatrics (impact factor:
0.52).
10/2002;
69(9):761-4.
DOI:10.1007/BF02723686
pp.761-4
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Pediatric gastrointestinal nuclear medicine.
[show abstract] [hide abstract]
ABSTRACT: General localization of gastrointestinal bleeding through the use of labeled red blood cells may be performed in children, or (99m)Tc-pertechnetate may be used if a Meckel's diverticulum is suspected. As in adults, cholecystitis and biliary leak may be assessed in children via (99m)Tc-IDA derivatives. Gastroesophageal reflux can be evaluated by oral consumption of the child's usual diet labeled with (99m)Tc sulfur colloid. For the scintigraphic determination of pulmonary aspiration, a relatively high concentration of tracer within a drop of liquid is placed beneath the child's tongue followed by dynamic imaging of the respiratory tract. Colonic transit scintigraphy can aid in the identification and therapeutic decision-making in patients with functional fecal retention, the most common cause of chronic constipation in children. (18)F-DOPA positron emission tomography is useful for classifying pancreatic involvement in infantile hyperinsulinism as focal or diffuse, thereby differentiating between patients who should receive curative focal pancreatic resection versus those who should receive medical management. Assessment of protein-losing enteropathy can be conducted scintigraphically and, compared with fecal alpha-1 antitrypsin collection, the scintigraphic method can detect esophageal and gastric protein loss. Also, scintigraphic quantification of protein loss can be performed without the requirement for fecal collection. Intestinal inflammation in children with inflammatory bowel disease can be evaluated using (99m)Tc white blood cells. The scintigraphic method is safe, accurate, well-tolerated by children and complementary to endoscopy in most patients.Seminars in Nuclear Medicine 08/2007; 37(4):269-85. · 4.31 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
alpha-1 antitrypsin
authors advocate
biofriendly molecule
detecting protein loss
diagnostic modality
diagnostic tool
endoscopic biopsy
enteropathy
fecal nitrogen excretion
imaging enteric protein loss
noninvasive
nonparticulate
patient preparation
patients
pediatric age group
protein-losing enteropathy
protien
Radiolabelling
stools
targeted approach